Theriva Biologics, Inc. Annual Operating Income (Loss) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Theriva Biologics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
  • Theriva Biologics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$7.89M, a 87% decline year-over-year.
  • Theriva Biologics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$28M, a 24.2% decline year-over-year.
  • Theriva Biologics, Inc. annual Operating Income (Loss) for 2023 was -$21.4M, a 0.7% increase from 2022.
  • Theriva Biologics, Inc. annual Operating Income (Loss) for 2022 was -$21.6M, a 51.2% decline from 2021.
  • Theriva Biologics, Inc. annual Operating Income (Loss) for 2021 was -$14.3M, a 40.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$21.4M +$150K +0.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-25
2022 -$21.6M -$7.31M -51.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
2021 -$14.3M -$4.11M -40.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$10.2M +$5.5M +35.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-16
2019 -$15.7M +$1.91M +10.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
2018 -$17.6M +$8.68M +33.1% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-20
2017 -$26.3M +$13M +33.1% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-27
2016 -$39.3M +$1.73M +4.22% Jan 1, 2016 Dec 31, 2016 10-K 2018-02-22
2015 -$41M -$20.5M -99.9% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-22
2014 -$20.5M -$8.16M -66.2% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-02
2013 -$12.3M +$4.96M +28.7% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-10
2012 -$17.3M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.